Safety And Long-Term Immunogenicity Of The 13-Valent Pneumococcal Conjugate Vaccine In Children Who Are Solid Organ Transplant Recipients
Latest Information Update: 16 Mar 2023
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 09 Mar 2023 Planned End Date changed from 30 Jun 2022 to 30 Jun 2024.
- 09 Mar 2023 Planned primary completion date changed from 31 Dec 2021 to 31 Dec 2023.
- 09 Aug 2021 Planned End Date changed from 30 Dec 2020 to 30 Jun 2022.